Business Description
Eupraxia Pharmaceuticals is a Canadian clinical-stage drug development company based in Victoria, founded in 2011. The company uses its proprietary Diffusphere platform to improve how drugs are delivered in the body, with a focus on conditions that currently lack effective treatments. Its lead programs target knee osteoarthritis and eosinophilic esophagitis, with trials at various stages of advancement.
